You are here

RAC Vaccines and Vaccination Group

Primary tabs

RAC Workgroup Efforts Focused on Vaccines and Vaccination

The Resilient American Communities (RAC) Vaccines and Vaccination Group is examining and acting on the issues surrounding vaccines development, distribution, vaccination logistics and execution, as well as vaccination strategy, safety, efficacy, trust, and hesitancy.  Special attention is currently focused on COVID-19 vaccines and vaccination. 

Members

Hank Rappaport Jan Booher John Girard Kathleen H mdmcdonald mike kraft

Email address for group

rac-vaccination@m.resiliencesystem.org

Researchers Are starting Clinical Trials on a New Type Low-Cost Coronavirus Vaccine

A new vaccine for Covid-19 that is entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic. The vaccine, called NVD-HXP-S, is the first in clinical trials to use a new molecular design that is widely expected to create more potent antibodies than the current generation of vaccines. And the new vaccine could be far easier to make.

Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.842 seconds.